腹水
肝性脑病
队列
肝移植
医学
门静脉压
经颈静脉肝内门体分流术
门脉高压
内科学
肝病
终末期肝病模型
危险系数
移植
胃肠病学
外科
置信区间
肝硬化
作者
Martin Kabelitz,Lukas Hartl,Golda Schaub,Anja Tiede,Hannah Rieland,Andrea Kornfehl,Peter Huebener,Mathias Jachs,Jan B. Hinrichs,Sarah Lisa Schütte,Christoph Riedel,Jim Benjamin Mauz,Tammo Lambert Tergast,B Meyer,Peter Bannas,Julia Kappel,Heiner Wedemeyer,Johannes Kluwe,Felix Piecha,Thomas Reiberger
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2025-01-03
卷期号:82 (5): 1172-1186
被引量:15
标识
DOI:10.1097/hep.0000000000001219
摘要
BACKGROUND AND AIMS: Clinically significant portal hypertension in patients with liver cirrhosis can lead to refractory ascites. A TIPS treats clinically significant portal hypertension but may cause overt hepatic encephalopathy (oHE). Our aim was to determine the optimal reduction of the portal pressure gradient (PPG) through TIPS to control ascites without raising oHE risk. APPROACH AND RESULTS: This multicenter study screened 1509 patients from 3 European centers (Hannover, Vienna, and Hamburg) undergoing TIPS implantation between 2000 and 2023. Patients with TIPS indications other than refractory ascites/hepatic hydrothorax, vascular liver disease, HCC, or insufficient PPG data were excluded. PPG was measured before and after TIPS insertion. Outcome data were assessed up to 1 year after TIPS insertion. Analyses were conducted utilizing a modern machine learning model, namely a competing-risk random survival forest, partial dependence plots, and competing risk analyses with liver transplantation/death as competitors. The cohort was divided into a 60% derivation and 40% validation cohort. Overall, 729 patients (median MELD: 13 [IQR 10-16], 66% male, 23% oHE before TIPS) were analyzed. The derivation cohort comprised 438 patients, and the validation cohort comprised 291 patients. The optimal PPG reduction, determined by maximally selected Gray statistic and PDP of the random survival forest, was 60%-80%. In this range, patients showed significantly fewer hepatic decompensations due to ascites (HDA) (subdistribution hazard ratio [sHR]: 0.7 [0.52-0.96]) with similar oHE incidences (sHR: 0.92 [0.67-1.27]). The PPG range was confirmed in the validation cohort (HDA: sHR: 0.66 [0.46-0.96]; oHE: sHR: 0.89 [0.61-1.32]). CONCLUSIONS: A targeted PPG reduction of 60%-80% showed significantly reduced HDA without increased oHE risk. Therefore, PPG reduction within this range could be a valid reduction target.
科研通智能强力驱动
Strongly Powered by AbleSci AI